USPH Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Despite Operational Consistency NCNA Q3 2024 Earnings Narrowed Loss Beats Expectations ResMed Q1 2026 Earnings EPS Beats Estimates but Stock Slips LYB Q1 2026 Earnings EPS Surges 140 Above Estimates Amid Improved Operations GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074 NIPG Q2 2025 Earnings Massive EPS Miss and Steep Stock Decline Raise Red Flags